# A Study of Sinotecean on Tolerance and Pharmacokinetics

> **NCT02469883** · PHASE1 · UNKNOWN · sponsor: **Chia Tai Tianqing Pharmaceutical Group Co., Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Advanced Cancer

## Interventions

- **DRUG:** Sinotecean

## Key facts

- **NCT ID:** NCT02469883
- **Lead sponsor:** Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2016-08
- **Final completion:** 2016-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2015-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02469883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02469883, "A Study of Sinotecean on Tolerance and Pharmacokinetics". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02469883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*